Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
alcohol dependence
Biotech
Altimmune GLP-1 curbs heavy drinking in ‘unequivocal’ ph. 2 win
Altimmune intends to next meet with the FDA to discuss the results and plan a potential path forward for pemvidutide in the indication.
Darren Incorvaia
Jul 28, 2026 10:27am
Pear nabs FDA breakthrough tag for alcoholism digital therapy
Nov 22, 2021 11:55am
Psilocybin shows promise in rat models of alcohol use disorder
Nov 18, 2021 9:40am
Adial taps Finnish CRO Crown for phase 3 trial of alcohol abuse treatment
Nov 20, 2018 2:23pm
FDA approves mobile app to help treat substance abuse
Sep 14, 2017 3:00pm
FDA nod for connected alcohol breathalyzer
Jul 15, 2016 3:12pm
